Cutera Inc (CUTR):企業の財務・戦略的SWOT分析

◆英語タイトル:Cutera Inc (CUTR) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1596
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cutera Inc (CUTR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cutera Inc (Cutera) manufactures, designs, markets, and services medical and aesthetic devices. The company provides laser and energy based aesthetics systems such as pico technology, excel HR technology, excel V technology, Juliet technology, secret RF technology, truSculpt iD technology, truSculpt 3D technology, and xeo technology. Its products are used in treatment of face and body hair removal and skin revitalization. Cutera’s enlighten device is used for tattoo removals and the treatment of benign pigmented lesions. The company offers truSculpt that delivers deep and uniform heating to all body areas with comfort and ease. It has its operations in France, Australia, Belgium, Germany, Spain, the UK, Portugal, New Zealand, Japan, Switzerland, and the US. Cutera is headquartered in Brisbane, California, the US.

Cutera Inc Key Recent Developments

Mar 10,2020 Cutera claims Lutronic stole trade secrets
Feb 26,2020 Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results
Jan 12,2020 Cutera announces preliminary financial results for fourth quarter and full-year 2019
Nov 18,2019 Cutera appoints Fuad Ahmad as Interim CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cutera Inc – Key Facts
Cutera Inc – Key Employees
Cutera Inc – Key Employee Biographies
Cutera Inc – Major Products and Services
Cutera Inc – History
Cutera Inc – Company Statement
Cutera Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Cutera Inc – Business Description
Product Category: Consumables
Performance
Product Category: Skincare
Performance
Product Category: Systems
Performance
Geographical Segment: Asia (Excluding Japan)
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Rest of the world
Performance
Geographical Segment: The US
Performance
Cutera Inc – Corporate Strategy
Cutera Inc – SWOT Analysis
SWOT Analysis – Overview
Cutera Inc – Strengths
Cutera Inc – Weaknesses
Cutera Inc – Opportunities
Cutera Inc – Threats
Cutera Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cutera Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Cutera Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Cutera Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 10, 2020: Cutera claims Lutronic stole trade secrets
Feb 26, 2020: Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results
Jan 12, 2020: Cutera announces preliminary financial results for fourth quarter and full-year 2019
Nov 18, 2019: Cutera appoints Fuad Ahmad as Interim CFO
Nov 07, 2019: Cutera reports third quarter 2019 financial results
Aug 12, 2019: Cutera announces planned retirement of David B. Apfelberg, M.D., as member of the board of directors
Aug 08, 2019: Cutera reports second quarter 2019 financial results
Jul 09, 2019: Cutera announces appointment of David Mowry as Chief Executive Officer
May 09, 2019: Cutera reports first quarter 2019 financial results
Feb 20, 2019: Cutera reports fourth quarter and full year 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cutera Inc, Key Facts
Cutera Inc, Key Employees
Cutera Inc, Key Employee Biographies
Cutera Inc, Major Products and Services
Cutera Inc, History
Cutera Inc, Subsidiaries
Cutera Inc, Key Competitors
Cutera Inc, Ratios based on current share price
Cutera Inc, Annual Ratios
Cutera Inc, Annual Ratios (Cont...1)
Cutera Inc, Annual Ratios (Cont...2)
Cutera Inc, Interim Ratios
Cutera Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Cutera Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Cutera Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Cutera Inc, Performance Chart (2015 - 2019)
Cutera Inc, Ratio Charts
Cutera Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Cutera Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Cutera Inc (CUTR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carrizo Oil & Gas Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Carrizo Oil & Gas Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Carrizo Oil & Gas Inc (Carrizo) is an independent oil and gas company, which carries out exploration, development and production of oil and natural gas from several resources plays. It has pres …
  • Immune Pharmaceuticals Inc (IMNP):企業の財務・戦略的SWOT分析
    Summary Immune Pharmaceuticals Inc (Immune Pharma) formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designed …
  • Enterome Bioscience SA-製薬・医療分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • Arbor Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Arbor Pharmaceuticals LLC (Arbor) is a healthcare products provider that develops prescription products for the hospital, cardiovascular and pediatric segments. The company offers licensing, manufacturing, development and commercialization of late-stage prescription products. It also offers …
  • Pharnext SA (ALPHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharnext SA (Pharnext), formerly Pharnext SAS is a biopharmaceutical company that develops novel therapies for severe neurodegenerative diseases. The company offers pleotherapy, a proprietary research and development platform based on network pharmacology that uses wide genomic data to ident …
  • Ficosa International SA:企業の戦略・SWOT・財務情報
    Ficosa International SA - Strategy, SWOT and Corporate Finance Report Summary Ficosa International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • St. Augustine Gold and Copper Limited:企業の戦略・SWOT・財務情報
    St. Augustine Gold and Copper Limited - Strategy, SWOT and Corporate Finance Report Summary St. Augustine Gold and Copper Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Duvel Moortgat NV:企業の戦略的SWOT分析
    Duvel Moortgat NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Emera Inc (EMA):電力:M&Aディール及び事業提携情報
    Summary Emera Inc (Emera) is an energy and services company. It invests in electricity, natural gas and utility energy services. Through ownership and equity investments in various companies, Emera generates, transmits and distributes electricity; procures, transmits and distributes natural gas; mar …
  • GeoPark Ltd (GPRK):石油・ガス:M&Aディール及び事業提携情報
    Summary GeoPark Ltd (GeoPark) is an oil and gas exploration and production company that explores, develops and produces upstream oil and gas in Latin America. The company operates various blocks such as Colombia blocks, Chile blocks, Brazil blocks, Peru blocks and Argentina blocks. Its Colombia bloc …
  • Fiesta Mart, Inc.:企業の戦略的SWOT分析
    Fiesta Mart, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Natural Resource Partners L.P.:企業のM&A・事業提携・投資動向
    Natural Resource Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Natural Resource Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Sensorion SA (ALSEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • Concho Resources Inc.:企業の戦略・SWOT・財務情報
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to man …
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Communique I'm InTouch provides a secure and easy to use PC remote acces …
  • Demant AS (DEMANT):企業の財務・戦略的SWOT分析
    Demant AS (DEMANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Genting Berhad:企業の戦略・SWOT・財務情報
    Genting Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Prime Healthcare Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prime Healthcare Services Inc (Prime Healthcare) is a hospital management center that operates acute care hospitals. The center provides medical services such as emergency room, senior services, heart care services, behavioral health services, and others. It offers surgical services, wound h …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆